Catalyst overview
Research summary
This catalyst tracks a Phase 2 data readout for ORKA-002 (IL-17A/F Antibody) in Psoriasis. The expected timing is based on the latest available company guidance and may change.
08/10/26:- ORCA-SURGE Week 16 data accelerated to Q1 2027.
Verification
Confirm timing and program details against the company announcement or filing.